EDUCATION:

M.D. and Ph.D. Microbiology,
University of Minnesota

B.S. Microbiology,
University of Illinois Urbana-Champaign

CONTACT:

LinkedIn

Colonel (Retired) Kenneth Bertram, M.D., Ph.D.

Senior Advisor

Colonel (Retired) Dr. Kenneth A. Bertram is the Chief Operating Officer of the Armed Forces Institute of Regenerative Medicine and the Clinical Product Development Officer at the Wake Forest Institute for Regenerative Medicine in Winston-Salem, NC. He brings decades of experience in military medicine, biomedical research, and medical product development. Dr. Bertram retired in 2018 as Principal Assistant for Acquisition at the U.S. Army Medical Research and Materiel Command (USAMRMC), where he oversaw the advanced development, acquisition, and life-cycle management of medical products including drugs, vaccines, biologics, and medical devices. He also served as The Surgeon General’s Sponsor’s Representative to the FDA and as the Army’s Milestone Decision Authority for medical products.

A retired Colonel in the U.S. Army Medical Corps, Dr. Bertram served for 24 years in active duty. His leadership roles included Commander of the Walter Reed Army Institute of Research, Chief of Staff at USAMRMC, Director of the Congressionally Directed Medical Research Programs, and Chief of Hematology/Oncology at Madigan Army Medical Center. He holds M.D. and Ph.D. degrees in Microbiology from the University of Minnesota and a B.S. in Microbiology from the University of Illinois Urbana-Champaign. He completed his residency and fellowship training at Madigan Army Medical Center and has held faculty appointments at the University of Washington and the Uniformed Services University of the Health Sciences. He is a Fellow of the American College of Physicians (F.A.C.P.).

Dr. Bertram currently also serves as Chief Medical Officer for Echelon Med Tech, sits on the Scientific Advisory Board for BioBridge Global, and advises several companies and organizations in the fields of trauma, resuscitation, infectious diseases, neuropsychiatric conditions, and regenerative medicine.